U.S. Software Stock News

NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

A Look At eXp World Holdings (EXPI) Valuation After Recent Share Price Weakness

With no fresh company specific headlines driving trade, eXp World Holdings (EXPI) is drawing attention again as investors weigh its recent share performance against reported revenue of US$4.77b and a net loss of US$22.7m. See our latest analysis for eXp World Holdings. The recent share price of US$6.22 sits against a mixed backdrop, with a 30 day share price return of 3.84% contrasted with a 90 day share price return decline of 31.19% and a 1 year total shareholder return decline of 30.94%,...
NYSE:AMCR
NYSE:AMCRPackaging

How Amcor’s New Malaysian Healthcare Coating Hub (AMCR) Has Changed Its Investment Story

Amcor recently opened an advanced healthcare packaging coating facility in Subang Jaya, Selangor, investing over US$35 million to bring air-knife coating technology for sterile medical device packaging to Malaysia and the wider Southeast Asian region. By localizing production into a fully integrated site with dual sourcing, closed-loop controls, and in-line quality monitoring, Amcor aims to boost regional supply reliability and support faster commercialization for healthcare customers. We’ll...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Elanco Screwworm Authorizations Spark Questions On Livestock Role And Valuation

Elanco Animal Health (NYSE:ELAN) has received emergency use authorizations from the U.S. FDA and EPA for Negasunt Powder and Tanidil to combat New World screwworm in livestock. The approvals give veterinarians and producers immediate tools to prevent and treat infestations as the parasite threat approaches the U.S. border. The authorizations were coordinated with federal and state agencies and focus squarely on protecting U.S. animal health during a potential outbreak. For investors...
NYSE:TMO
NYSE:TMOLife Sciences

Is Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO?

Thermo Fisher Scientific recently opened its flagship U.S. Bioprocess Design Center at its Plainville, Massachusetts site, adding 4,000 square feet of lab and training space to help customers develop and scale biologics, including vaccines and cell and gene therapies. This expansion deepens Thermo Fisher’s end-to-end bioproduction offering by combining its full workflow of integrated, scalable solutions with onsite specialists who collaborate directly with customers to optimize processes and...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Is It Time To Reassess Fermi (FRMI) After The Sharp Year To Date Share Price Fall

If you are trying to figure out whether Fermi is attractively priced or not, the recent share performance gives you some very direct clues to work with. The stock last closed at US$5.13, with returns of a 13.3% decline over 7 days, a 12.2% decline over 30 days, and a 41.8% decline year to date, which will shape how you think about both potential upside and risk. Recent coverage has focused on how this pullback has put more attention on whether the current share price lines up with Fermi's...
NasdaqGS:SIMO
NasdaqGS:SIMOSemiconductor

Is It Too Late To Consider Silicon Motion Technology (NasdaqGS:SIMO) After Its 345.9% Surge?

If you are wondering whether Silicon Motion Technology at US$218.78 still offers value after a strong run, this article walks through what the current price might imply. The stock has posted returns of 54.1% over the last 7 days, 94.8% over 30 days, 133.3% year to date, and 345.9% over the past year, which can change how investors weigh both potential and risk. Recent headlines have focused on Silicon Motion Technology within the context of broader interest in semiconductor names and market...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

How Investors May Respond To Credit Acceptance (CACC) Hiring a New Chief Sales Officer

In late April 2026, Credit Acceptance Corporation reported that Robert Bourrier has joined as Chief Sales Officer, tasked with leading and scaling the national sales organization to drive disciplined revenue growth, market share expansion, and consistent execution across all markets. This hire brings more than 25 years of sales and commercial leadership experience from sectors such as private aviation and global airlines, signaling a push to tighten sales execution, strengthen performance...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Is It Time To Reconsider Corpay (CPAY) After Mixed Returns And Fintech Headlines

If you are wondering whether Corpay at around US$306 per share still offers value or is starting to look expensive, the key is to look past the headline price and focus on what you are getting for it. The stock has been mixed recently, with a 2.2% decline over the last 7 days, a 5.3% gain over the past month, a 2.0% gain year to date, and a 5.0% decline over the last year, alongside a 37.1% return over three years and 7.0% over five years. Recent news around Corpay has focused on its role in...
NYSE:ET
NYSE:ETOil and Gas

Does Energy Transfer (ET)'s Higher Payout Clarify Its Long‑Term Income Strategy Or Complicate It?

Energy Transfer LP recently increased its quarterly cash distribution to US$0.3375 per common unit (US$1.35 annualized) for the first quarter of 2026, payable on May 20 to unitholders of record on May 8, and also declared a US$0.2111 quarterly payment on its Series I preferred units, scheduled for May 15. This latest distribution increase of more than 3% aligns with Energy Transfer’s stated aim of delivering steady, incremental income growth after its 2020 distribution cut and balance sheet...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp Google Cloud AI Push Highlights Valuation Gap And Growth Questions

NetApp (NasdaqGS:NTAP) announced new capabilities with Google Cloud at Google Cloud Next 2026. The collaboration focuses on simplifying how customers deploy AI workloads and enterprise applications in Google Cloud. The approach is designed to let enterprises use cloud based AI without rearchitecting existing environments. For investors watching cloud data infrastructure, NetApp sits at the intersection of storage, data management, and enterprise IT, areas that are central to AI heavy...
NYSE:ECG
NYSE:ECGConstruction

Is It Too Late To Consider Everus Construction Group (ECG) After Its 244% One Year Surge?

If you are wondering whether Everus Construction Group is priced attractively or starting to look stretched, the recent share activity gives a useful starting point for a closer look at value. The stock closed at US$147.43, with returns of 8.1% over 7 days, 24.9% over 30 days, 65.3% year to date and 244.1% over 1 year, which puts valuation questions firmly on the table for any investor tracking the name. Recent coverage has focused on Everus Construction Group's strong share price...
NYSE:APH
NYSE:APHElectronic

Is It Too Late To Consider Buying Amphenol (APH) After Its 88% One Year Rally?

If you are wondering whether Amphenol's current share price still offers value after a strong run, the next sections break down what the numbers are really saying about the stock. Amphenol's share price last closed at US$147.27, with returns of 16.6% over the past month, 5.4% year to date, and 88.6% over the past year, while the 7 day move has been a 1.9% decline. Recent coverage has focused on Amphenol's role as a major connector and cable producer in the electronics sector and how investor...
NasdaqGS:COLB
NasdaqGS:COLBBanks

How Franchise Banking Push and Buybacks at Columbia (COLB) Have Changed Its Investment Story

In the first quarter ended March 31, 2026, Columbia Banking System reported unaudited net charge-offs of US$35 million, net interest income of US$594 million, and net income of US$192 million, while also completing a US$299.73 million share repurchase program covering 10,180,000 shares. Columbia Bank, the company’s banking subsidiary, has also launched a Franchise Banking Team led by industry veterans James Short and Rich Watson to expand tailored services for restaurant franchisors and...
NYSE:SW
NYSE:SWPackaging

Smurfit Westrock (SW) Margin Improvement Challenges Bearish Narrative In Q1 2026 Results

Smurfit Westrock (NYSE:SW) has just put fresh numbers on the table for Q1 2026, following a run where quarterly revenue has sat around US$7.5 billion to US$8.0 billion and EPS moved between US$0.19 and US$0.74 over the past year, alongside trailing 12 month earnings growth of 119.1%. Over recent quarters the company has seen revenue range from US$7.5 billion in Q4 2025 up to US$8.0 billion in Q3 2025, while basic EPS has swung from a loss of US$0.05 in Q2 2025 to US$0.74 in Q1 2025 and 1.34...
NYSE:UNH
NYSE:UNHHealthcare

A Look At UnitedHealth Group’s Valuation After Recent Short Term Share Price Strength

Recent performance snapshot for UnitedHealth Group (UNH) UnitedHealth Group (UNH) has drawn investor interest after recent share price moves, with the stock up around 4% over the past week, about 37% over the past month, and roughly 29% in the past 3 months. See our latest analysis for UnitedHealth Group. While the recent 30 day share price return of 36.9% and 90 day return of 29.1% suggest strong short term momentum around the current US$370.48 level, the 1 year total shareholder return of a...
NYSE:CPT
NYSE:CPTResidential REITs

Is Camden Property Trust (CPT) Pricing Reflect Recent REIT Sentiment Shift?

Wondering if Camden Property Trust at around US$105 is offering value or asking too much? This article breaks down what the current price might actually reflect. The stock has a recent 7 day return of 2.5% and a 30 day return of 7.5%, yet sits on a year to date return of a 4.7% decline and a 1 year return of a 4.8% decline. This raises questions about how the market is reassessing risk and opportunity here. Recent coverage has focused on Camden Property Trust as a residential REIT, with...
NYSE:HP
NYSE:HPEnergy Services

Is It Too Late To Look At Helmerich & Payne (HP) After A 115% One-Year Surge?

If you are wondering whether Helmerich & Payne, at a last close of US$40.38, still offers value after a strong run, the key is understanding what the current price actually reflects. The stock has posted returns of 7.5% over the last 7 days, 12.1% over 30 days, 34.9% year to date, and 114.8% over 1 year. The question now is whether that performance lines up with the underlying value or has shifted the risk and reward balance. Recent coverage has focused on Helmerich & Payne's role in the...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

T. Rowe Price Extends Alternatives Push As Market Reassesses Valuation

T. Rowe Price Group (NasdaqGS:TROW) is expanding further into alternative investments and outcome oriented solutions through a deeper partnership with Oak Hill Advisors. The firm is working with Goldman Sachs on new offerings, including upcoming ETF launches in Europe and interval funds. The build out of private credit and other alternative products comes as the company focuses on stabilizing outflows and improving operational efficiency. T. Rowe Price Group, trading at about $102.88, is...
NYSE:PNR
NYSE:PNRMachinery

Is Pentair’s (PNR) Upgraded EPS Outlook and Reorganization Quietly Redefining Its Margin Story?

Pentair plc recently reported first-quarter 2026 results showing sales of US$1,036.7 million and higher earnings per share year over year, while also updating guidance to higher full-year GAAP EPS and operating income expectations. Alongside the earnings release, Pentair announced a leadership reshuffle that consolidates its Flow, Water Solutions and Pool segments under one executive, signaling an effort to streamline decision-making and execution across its core water businesses. Now we’ll...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Assessing Monster Beverage (MNST) Valuation After Recent Share Price Pullback

Stock performance snapshot Monster Beverage (MNST) has drawn investor attention after a recent move that left the stock around $77.07, with a roughly 6% gain over the past month but a 5% decline over the past 3 months. See our latest analysis for Monster Beverage. That recent 6% 1 month share price return sits against a quieter year to date move of 1.2% for the share price, while the 1 year total shareholder return of 29.5% points to stronger longer term momentum that the latest pullback over...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

CleanSpark (CLSK) Valuation Check As Traders React To Softer Earnings Outlook And Cautious Analyst Rating

CleanSpark (CLSK) recently fell 4% as traders focused on an upcoming earnings release that is expected to show lower EPS and revenue versus last year, along with a Zacks Rank of #4 (Sell). See our latest analysis for CleanSpark. That 4% drop came even as CleanSpark has a 30 day share price return of 47.24% and a 1 year total shareholder return of 44.52%. The 3 year total shareholder return is about 3x, suggesting recent volatility is occurring against a much larger move over time. If you are...